In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...
Christian Angermayer, Apeiron Investment Group founder, joins 'Squawk Box' to discuss President Trump's executive order ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
23hon MSNOpinion
Placebo effect can work as well as real medicine – but your body may need permission to use it
The first time the placebo effect really got under my skin was when I read that roughly one-third of people with irritable ...
Researchers at the University of Colorado Anschutz may have identified why many cancer patients say food suddenly tastes ...
Sign up for Today's Best Articles in your inbox A free daily email with the biggest news stories of the day – and the best ...
Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.
As more people turn to GLP-1 medications for weight loss, doctors are drawing attention to a possible side effect that some ...
New drugs approved in 2025 are poised to significantly improve the management of motion sickness, acute pain, urinary tract infections (UTIs), and chronic spontaneous urticaria. Gerald W. Smetana, MD, ...
Roche Holding AG’s experimental multiple sclerosis pill sharply reduced relapses in late-stage trials, strengthening its case ...
Jazz Pharma's Ziihera and Eli Lilly's Jaypirca, respectively – have been recommended by reimbursement agency NICE for NHS use ...
Some researchers are delighted at an executive order to streamline investigations of psychedelics but also warn that caution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results